glp-1 blockers in food companies are targeting users of weight-loss drugs with 'GLP-1 Friendly' labels GLP-1 Boom: US/UK Restaurants &
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 152.Liu, T., Ji, R
These events were most common early in treatment, especially without ramp-up dosing
Though often mentioned alongside GLP-1, glucagon has a different role in energy regulation
Some patients may experience mild nausea, especially at the beginning
Patients on tirzepatide may achieve up to 20% weight loss over a similar timeframe
